Emergence of KPC-31, a KPC-3 Variant Associated with Ceftazidime-Avibactam Resistance, in an Extensively Drug-Resistant ST235 Pseudomonas aeruginosa Clinical Isolate
- PMID: 36286541
- PMCID: PMC9664854
- DOI: 10.1128/aac.00648-22
Emergence of KPC-31, a KPC-3 Variant Associated with Ceftazidime-Avibactam Resistance, in an Extensively Drug-Resistant ST235 Pseudomonas aeruginosa Clinical Isolate
Abstract
A ceftazidime-avibactam-resistant KPC-producing Pseudomonas aeruginosa strain was isolated in Argentina from a tracheal aspirate. The patient was treated with ceftazidime-avibactam in combination with other agents for 130 days. Whole-genome sequencing of P. aeruginosa identified a D179Y substitution in the Ω loop of KPC-3, corresponding to KPC-31, integrated at the chromosome. The strain belonged to the sequence type 235/O11 (ST235/O11) high-risk clone. Evaluation of carbapenemase detection assays most used by clinical laboratories failed to identify the isolate as a KPC producer.
Keywords: KPC; Pseudomonas aeruginosa; ceftazidime-avibactam resistance; extensively drug-resistant ST235.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Pasteran F, Faccone D, Gomez S, De Bunder S, Spinelli F, Rapoport M, Petroni A, Galas M, Corso A, on behalf of the Pseudomonas aeruginosa KPC Group . 2012. Detection of an international multiresistant clone belonging to sequence type 654 involved in the dissemination of KPC-producing Pseudomonas aeruginosa in Argentina. J Antimicrob Chemother 67:1291–1293. 10.1093/jac/dks032. - DOI - PubMed
-
- Castanheira M, Doyle TB, Smith CJ, Mendes RE, Sader HS. 2019. Combination of MexAB-OprM overexpression and mutations in efflux regulators, PBPs and chaperone proteins is responsible for ceftazidime/avibactam resistance in Pseudomonas aeruginosa clinical isolates from US hospitals. J Antimicrob Chemother 74:2588–2595. 10.1093/jac/dkz243. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
